Source:http://linkedlifedata.com/resource/pubmed/id/19251316
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
15
|
| pubmed:dateCreated |
2009-3-23
|
| pubmed:abstractText |
HER2 detection is important for breast cancer (BC) treatment and prognosis, but the detection methods currently used have some disadvantages. Quantum dots (QDs)-based probes provide a potentially important new method for HER2 detection in clinical practice. This potential is examined in this paper. A QDs HER2 probe kit and QDs image acquisition and analysis software were developed and applied to 94 clinical samples of BC. Compared to conventional immunohistochemistry techniques, this method provided a superior accurate and sensitive method for the detection of HER2 in clinical breast cancer diagnosis.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1878-5905
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2912-8
|
| pubmed:meshHeading |
pubmed-meshheading:19251316-Breast Neoplasms,
pubmed-meshheading:19251316-Feasibility Studies,
pubmed-meshheading:19251316-Fluorescent Antibody Technique,
pubmed-meshheading:19251316-Genes, erbB-2,
pubmed-meshheading:19251316-Humans,
pubmed-meshheading:19251316-Quantum Dots,
pubmed-meshheading:19251316-Sensitivity and Specificity
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer.
|
| pubmed:affiliation |
Department of Oncology, Zhongnan Hospital of Wuhan University, Wuchang District, PR China.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|